Physician profile
Stephen Caso
NPI 1083916985
$13,098.34
in general payments reported to CMS, 2019-2025
68 companies · $2,365 in 2025
The $2,365 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,190 · 2022: $2,336 · 2023: $2,270 · 2024: $2,939 · 2025: $2,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,573.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,540.22 | 2021-2025 | |
| Amgen INC. | $1,165.12 | 2021-2025 | Evenity, Repatha, Prolia |
| Glaxosmithkline, LLC. | $854.74 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $809.27 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $789.96 | 2021-2025 | Mounjaro, Jardiance, Kisunla |
| Gilead Sciences, INC. | $723.07 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $590.06 | 2021-2025 | |
| Novo Nordisk INC | $522.54 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Inspire Medical Systems, INC. | $406.49 | 2023-2025 | Inspire |
| Exact Sciences Corporation | $341.98 | 2023-2025 | Cologuard Collection Kit |
| Genzyme Corporation | $334.56 | 2024 | |
| Pfizer INC. | $334.46 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $333.37 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $324.19 | 2021-2025 | Austedo Xr |
| Radius Health, INC. | $295.51 | 2021 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $278.49 | 2021-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.25 | 2023-2025 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $245.65 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $231.18 | 2022 | |
| Phadia US INC. | $210.76 | 2024-2025 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.89 | 2021-2025 | Jardiance, Ofev |
| Esperion Therapeutics, INC. | $166.39 | 2021-2025 | Nexletol |
| Stryker Corporation | $165.27 | 2023 | Clarifix Cryotherapy Device |
| Hologic Sales and Service, LLC | $158.74 | 2023-2025 | Aptima |
| Biohaven Pharmaceuticals, INC. | $144.57 | 2021 | |
| Merck Sharp & Dohme LLC | $117.18 | 2021-2022 | |
| Neurent Medical Limited | $114.63 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Currax Pharmaceuticals LLC | $91.47 | 2022-2023 | Contrave, Onzetra Xsail |
| Bausch Health US, LLC | $85.87 | 2022 | |
| Myriad Women'S Health, INC. | $83.99 | 2023 | Myrisk |
| Amarin Pharma, INC. | $69.97 | 2021-2022 | |
| Heartflow, INC. | $64.77 | 2024 | |
| Philips North America LLC | $64.58 | 2023-2025 | Extended Holter, (Ck4) Mcot |
| Janssen Pharmaceuticals, INC | $64.50 | 2021-2025 | Spravato |
| Ibsa Pharma INC. | $58.79 | 2021 | |
| Antares Pharma, INC. | $51.27 | 2025 | Xyosted |
| Phathom Pharmaceuticals, INC. | $46.42 | 2024-2025 | Voquezna |
| Alk-Abello, INC | $45.64 | 2024 | Ragwitek, Grastek, Odactra |
| Alnylam Pharmaceuticals INC. | $40.50 | 2023 | Givlaari |
| Boston Scientific Corporation | $39.84 | 2022-2024 | Watchman Flx |
| Eisai INC. | $39.18 | 2021 | |
| Daiichi Sankyo INC. | $36.96 | 2021 | |
| Organon LLC | $35.11 | 2024 | |
| Therapeuticsmd, INC. | $34.68 | 2021 | |
| Arbor Pharmaceuticals, INC. | $34.52 | 2021 | |
| Axsome Therapeutics, INC. | $31.12 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $28.37 | 2024 | Rexulti |
| Biogen, INC. | $27.27 | 2025 | Zurzuvae |
| Incyte Corporation | $27.12 | 2025 | Opzelura |
| Grifols USA, LLC | $24.58 | 2024 | Prolastin-C Liquid |
| Irhythm Technologies, INC. | $23.85 | 2024 | Zio Monitor, Zio Xt Patch |
| Sumitomo Pharma America, INC. | $22.90 | 2024 | Gemtesa |
| Abbott Laboratories | $22.74 | 2025 | Aveir |
| Coopersurgical, INC. | $21.57 | 2024 | Paragard T 380a |
| Lundbeck LLC | $20.69 | 2021 | |
| Corcept Therapeutics | $19.89 | 2025 | Korlym |
| Optinose US, INC. | $19.42 | 2024 | |
| Alfasigma USA, INC. | $17.93 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.76 | 2022 | |
| Tactile Systems Technology INC | $15.90 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.60 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.22 | 2022 | |
| Azurity Pharmaceuticals, INC. | $14.79 | 2023 | Horizant |
| Shield Therapeutics INC | $14.48 | 2022 | |
| Cequr Corporation | $14.05 | 2023 | Cequr Simplicity |
| Avion Pharmaceuticals | $13.87 | 2023 | Methylphenidate Hydrochloride |
| Sanofi Pasteur INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Caso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.